Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Henry Bienen Insider Profile
4 Followers
Henry Bienen, Director at Traws Pharma, holds 27.42K shares in Ryan Specialty Group (Ticker: RYAN), holds 22.72K shares in Traws Pharma (Ticker: TRAW), holds ― shares in Gleacher & Company (Ticker: GLCH).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-56.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Henry Bienen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Henry Bienen
Henry Bienen's Trading History
Traws Pharma
May 31, 2018
Director
Informative Buy
3.80K
$15.11K
Ryan Specialty Group
Sep 01, 2023
Director
Uninformative Sell
―
$1.40M
Gleacher & Company
May 25, 2012
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Henry Bienen's performance on stock
You May Also Like
Henry Bienen insider profile FAQ
What is the percentage of profitable transactions made by Henry Bienen?
The percentage of profitable transactions made by Henry Bienen is 0%.
What is the average return per transaction made by Henry Bienen?
The average return per transaction made by Henry Bienen is -56.30%.
What stocks does Henry Bienen hold?
Henry Bienen holds: TRAW, RYAN, GLCH stocks.
What was Henry Bienen’s latest transaction?
Henry Bienen latest transaction was an Uninformative Sell of ―.
What was Henry Bienen's most profitable transaction?
Henry Bienen’s most profitable transaction was an Informative Buy of TRAW stock on August 10, 2016. The return on the trade was -40.60%.
What is Henry Bienen's role in Traws Pharma?
Henry Bienen's role in Traws Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.